208 related articles for article (PubMed ID: 17493524)
21. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
Meissner M; Whiteside TL; Kaufmann R; Seliger B
Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
[TBL] [Abstract][Full Text] [Related]
22. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
23. Response of glioma cells to interferon-gamma: increase in class II RNA, protein and mixed lymphocyte reaction-stimulating ability.
Takiguchi M; Ting JP; Buessow SC; Boyer C; Gillespie Y; Frelinger JA
Eur J Immunol; 1985 Aug; 15(8):809-14. PubMed ID: 2411569
[TBL] [Abstract][Full Text] [Related]
24. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
Broxmeyer HE; Cooper S; Hangoc G; Chang CH
Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
[TBL] [Abstract][Full Text] [Related]
25. Differential induction of stromelysin mRNA by bovine articular chondrocytes treated with interferon-gamma and interleukin-1 alpha.
Quintavalla JC; Berg RA; Beavis AJ; Piccoli SP; Rediske JJ; Kurkinen M; Patrick RA; Robertson FM
J Cell Physiol; 1993 Jan; 154(1):113-21. PubMed ID: 8419398
[TBL] [Abstract][Full Text] [Related]
26. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
27. Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor.
Mueller RB; Skapenko A; Grunke M; Wendler J; Stuhlmuller B; Kalden JR; Schulze-Koops H
Arthritis Rheum; 2005 Feb; 52(2):451-60. PubMed ID: 15692975
[TBL] [Abstract][Full Text] [Related]
28. [Biological activity of C II TA anti-sense RNA--a novel approach to inhibition of rejection in transplantation].
Guo R; Zou P; Du X; Zhag M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):848-51. PubMed ID: 16277856
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27.
Feng XM; Liu N; Yang SG; Hu LY; Chen XL; Fang ZH; Ren Q; Lu SH; Liu B; Han ZC
Biochem Biophys Res Commun; 2008 Mar; 367(3):553-9. PubMed ID: 18178151
[TBL] [Abstract][Full Text] [Related]
30. HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon.
Wang D; Levasseur-Acker GM; Jankowski R; Kanny G; Moneret-Vautrin DA; Charron D; Lockhart A; Swierczewski E
Clin Exp Allergy; 1997 Mar; 27(3):306-14. PubMed ID: 9088657
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of IL-10 protein synthesis induces major histocompatibility complex class II gene expression in class II-deficient patients.
Hauber I; Wolf HM; Samstag A; Pein B; Kreil TR; Gulle H; Fischer MB; Eibl MM
Cell Immunol; 1997 Sep; 180(2):95-103. PubMed ID: 9341739
[TBL] [Abstract][Full Text] [Related]
32. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma.
Liversidge JM; Sewell HF; Forrester JV
Clin Exp Immunol; 1988 Sep; 73(3):489-94. PubMed ID: 3145163
[TBL] [Abstract][Full Text] [Related]
33. Downregulating immunogenicity of Schwann cells via inhibiting a potential target of class II transactivator (CIITA) gene.
Yang Y; Dai W; Chen Z; Yan Z; Yao Z; Zhang C
Biosci Trends; 2013 Feb; 7(1):50-5. PubMed ID: 23524893
[TBL] [Abstract][Full Text] [Related]
34. 15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism.
Willermain F; Dulku S; Gonzalez NS; Blero D; Driessens G; De Graef C; Caspers L; Bruyns C
Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):136-43. PubMed ID: 16939878
[TBL] [Abstract][Full Text] [Related]
35. Modulation of MHC class II expression in human cells by dexamethasone.
Schwiebert LM; Schleimer RP; Radka SF; Ono SJ
Cell Immunol; 1995 Oct; 165(1):12-9. PubMed ID: 7671315
[TBL] [Abstract][Full Text] [Related]
36. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681
[TBL] [Abstract][Full Text] [Related]
37. Mutant human B cell lines deficient in class II major histocompatibility complex transcription.
Calman AF; Peterlin BM
J Immunol; 1987 Oct; 139(7):2489-95. PubMed ID: 3116083
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 Tat mutants in the cysteine-rich region downregulate HLA class II expression in T lymphocytic and macrophage cell lines.
Tosi G; De Lerma Barbaro A; D'Agostino A; Valle MT; Megiovanni AM; Manca F; Caputo A; Barbanti-Brodano G; Accolla RS
Eur J Immunol; 2000 Jan; 30(1):19-28. PubMed ID: 10602023
[TBL] [Abstract][Full Text] [Related]
39. Rat connective tissue-type mast cells express MHC class II: up-regulation by IFN-gamma.
Warbrick EV; Taylor AM; Botchkarev VA; Coleman JW
Cell Immunol; 1995 Jul; 163(2):222-8. PubMed ID: 7606795
[TBL] [Abstract][Full Text] [Related]
40. Expression of major histocompatibility complex antigens in squamous cell carcinomas of the head and neck: effects of interferon gene transfer.
Arosarena OA; Baranwal S; Strome S; Wolf GT; Krauss JC; Bradford CR; Carey TE
Otolaryngol Head Neck Surg; 1999 May; 120(5):665-71. PubMed ID: 10229590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
